Smruthi Organics Limited

BSE:540686 Stock Report

Market Cap: ₹1.8b

Smruthi Organics Past Earnings Performance

Past criteria checks 1/6

Smruthi Organics's earnings have been declining at an average annual rate of -12.5%, while the Pharmaceuticals industry saw earnings growing at 17% annually. Revenues have been declining at an average rate of 0.5% per year. Smruthi Organics's return on equity is 5.2%, and it has net margins of 2.8%.

Key information

-12.5%

Earnings growth rate

-12.4%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate-0.5%
Return on equity5.2%
Net Margin2.8%
Next Earnings Update27 Jul 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Smruthi Organics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:540686 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 241,276361720
31 Dec 231,248281760
30 Sep 231,332521680
30 Jun 231,469611620
31 Mar 231,410411580
31 Dec 221,397481450
30 Sep 221,443821450
30 Jun 221,315821390
31 Mar 221,3341041370
31 Dec 211,2661181740
30 Sep 211,2181351710
30 Jun 211,2811671700
31 Mar 211,2651711180
31 Dec 201,2781591490
30 Sep 201,2691321420
30 Jun 201,280921330
31 Mar 201,311841360
31 Dec 191,419781540
30 Sep 191,500771480
30 Jun 191,416751400
31 Mar 191,374691290
31 Dec 181,26891870
30 Sep 181,100-11800
30 Jun 181,070-9990
31 Mar 18973-321720
31 Dec 1789134880
30 Sep 1786226850
30 Jun 1777212810
31 Mar 1779416790
31 Dec 1679318800
30 Sep 167756770
30 Jun 1675311760
31 Mar 167267750
31 Dec 1575218912
30 Sep 157150832
30 Jun 15656-28762
31 Mar 15748-38630
31 Dec 14761-85774
30 Sep 14829-92884
30 Jun 14953-66850
31 Mar 14918-621014
31 Dec 13831-681079
30 Sep 131,129-191169

Quality Earnings: 540686 has high quality earnings.

Growing Profit Margin: 540686's current net profit margins (2.8%) are lower than last year (2.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 540686's earnings have declined by 12.5% per year over the past 5 years.

Accelerating Growth: 540686's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 540686 had negative earnings growth (-13.1%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (18%).


Return on Equity

High ROE: 540686's Return on Equity (5.2%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.